PRQR
Proqr Therapeutics
$1.73
+$0.01 (+0.58%)Jul 27, 2026
Key metrics
The numbers that frame PRQR today
- Market cap
- $186.34M
- P/E (TTM)
- -3.5
- EV / FCF
- -1.8
- Gross margin
- 100%
- EV / Sales
- 6.8
- ROIC
- -3,620.8%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $1.33
- 52wk High
- $3.10
Growth
Revenue and earnings trend for PRQR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PRQR
Is Proqr Therapeutics a good buy?
No. Proqr Therapeutics has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Proqr Therapeutics is selling at a very high price.
What is the market capitalization of PRQR?
Proqr Therapeutics's market capitalization is $186.34M.
What is the P/E ratio for PRQR stock?
Proqr Therapeutics's current P/E ratio is -3.5.
What is the 52-week high for PRQR stock?
The 52-week high for Proqr Therapeutics is $3.10. The current close of $1.73 is 44.2% below that high.
What is the 52-week low for PRQR stock?
The 52-week low for Proqr Therapeutics is $1.33. The current close of $1.73 is 30.1% above that low.
Does PRQR stock pay dividends?
Proqr Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PRQR?
Proqr Therapeutics's Debt / Equity ratio is 0.42.